Fusion proteins comprising a noncytotoxic protease, a targeting moiety, a protease cleavage site and a translocation domain

Details for Australian Patent Application No. 2005311106 (hide)

Owner Syntaxin Limited

Inventors Durose, Lyndsey; Foster, Keith; Chaddock, John; Stancombe, Patrick; Marks, Philip

Agent Freehills

Pub. Number AU-B-2005311106

PCT Pub. Number WO2006/059113

Priority 0426397.6 01.12.04 GB

Filing date 1 December 2005

Wipo publication date 8 June 2006

Acceptance publication date 26 May 2011

International Classifications

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/059113 Priority application(s): WO2006/059113

29 November 2007 Assignment before Grant

  Health Protection Agency The application has been assigned to Syntaxin Limited

26 May 2011 Application Accepted

  Published as AU-B-2005311106

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005311109-Imaging apparatus

2005311103-PLAD domain peptides with increased serum half life due to conjugation to domain antibodies